Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections

PLoS Genetics

Volumn 12, Issue 7, 2016, Pages

  Nourmohammad, Armita ^a   Otwinowski, Jakub ^b   Plotkin, Joshua B ^b  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; NEUTRALIZING ANTIBODY; ANTIGEN;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL COUNT; GENE FREQUENCY; GENE MUTATION; GENETIC VARIATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PHYLOGENY; POPULATION SIZE; VIRUS ATTACHMENT; ADAPTIVE IMMUNITY; BIOLOGICAL MODEL; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MOLECULAR EVOLUTION; VIROLOGY;

ADAPTIVE IMMUNITY; ANTIBODIES, NEUTRALIZING; ANTIGENS; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, GENETIC;

EID: 84982795845     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006171     Document Type: Article

References (59)

1. Janeway C. A, Travers P, Walport M, Shlomchik M, . (2005) Immunobiology: The Immune System in Health and Disease (Garland Science, New York).
2. Elhanati Y, Sethna Z, Marcou Q, Callan C. G, Mora T, Walczak A, . (2015) Inferring processes underlying B-cell repertoire diversity. Phil. Trans. R. Soc. B370. doi: 10.1098/rstb.2014.024326194757
3. Trepel F, . (1974) Number and distribution of lymphocytes in man. A critical analysis. Klin. Wochenschrift52, 511–515. doi: 10.1007/BF01468720
4. Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta G. R, et al. (2009) Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc. Natl. Acad. Sci. U.S.A.106, 20216–20221. doi: 10.1073/pnas.090977510619875695
5. Odegard V. H, Schatz D. G, . (2006) Targeting of somatic hypermutation. Nature Rev. Immunol.6, 573–583. doi: 10.1038/nri1896
6. Campbell C. D, Eichler E. E, . (2013) Properties and rates of germline mutations in humans. Trends. Genet.29, 575–584. doi: 10.1016/j.tig.2013.04.00523684843
7. Meyer-Hermann M, Mohr E, Pelletier N, Zhang Y, Victora G. D, Toellner K, . (2012) A theory of germinal center B cell selection, division, and exit. Cell Rep.2, 162–174. doi: 10.1016/j.celrep.2012.05.01022840406
8. Victora G. D, Nussenzweig M. C, . (2012) Germinal centers. Annu. Rev. Immunol.30, 429–457. doi: 10.1146/annurev-immunol-020711-07503222224772
9. Cobey S, Wilson P, Matsen F. A, . (2015) The evolution within us. Phil. Trans. R. Soc. B370. doi: 10.1098/rstb.2014.0235
10. Duffy S, Shackelton L. A, Holmes E. C, . (2008) Rates of evolutionary change in viruses: patterns and determinants. Nature Rev. Genet.9, 267–276. doi: 10.1038/nrg232318319742
11. Richman D. D, Wrin T, Little S. J, Petropoulos C. J., (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A.100, 4144–4149. doi: 10.1073/pnas.063053010012644702
12. Frost S. D. W, Wrin T, Smith D. M, Kosakovsky Pond S. L, Liu Y, Paxinos E, et al. (2005) Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U.S.A.102, 18514–18519. doi: 10.1073/pnas.050465810216339909
13. Moore P. L, Ranchobe N, Lambson B. E, Gray E. S, Cave E, Abrahams M.-R, et al. (2009) Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog.5, e1000598. doi: 10.1371/journal.ppat.100059819763271
14. Liao H.-X, Lynch R, Zhou T, Gao F, Alam S. M, Boyd S. D, et al. (2013) Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature496, 469–476. doi: 10.1038/nature1205323552890
15. Luo S, Perelson A. S, . (2015) The challenges of modelling antibody repertoire dynamics in HIV infection. Phil. Trans. R. Soc. B370. doi: 10.1098/rstb.2014.024726194760
16. Kwong P. D, Doyle M. L, Casper D. J, Cicala C, Leavitt S. A, Majeed S, et al. (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature420, 678–682. doi: 10.1038/nature0118812478295
17. Lyumkis D, Julien J-P, de Val N, Cupo A, Potter C. S, Klasse P-J, et al. (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science342, 1484–1490. doi: 10.1126/science.124562724179160
18. Simek M. D, Rida W, Priddy F. H, Pung P, Carrow E, Laufer D. S, et al. (2009) Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol.83, 7337–7348. doi: 10.1128/JVI.00110-0919439467
19. Doria-Rose N. A, Klein R. M, Daniels M. G, O’Dell S, Nason M, Lapedes A, et al. (2010) Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. J. Virol.84, 1631–1636. doi: 10.1128/JVI.01482-0919923174
20. Walker L. M, Phogat S. K, Chan-Hui P-Y, Wagner D, Phung P, Goss J. L, et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science326, 285–289. doi: 10.1126/science.117874619729618
21. Chen L, Kwon Y. D, Zhou T, Wu X, O’Dell S, Cavacini L, et al. (2009) Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science326, 1123–1127. doi: 10.1126/science.117586819965434
22. Zhou T, Georgiev I, Wu X, Yang Z-Y, Dai K, Finzi A, et al. (2010) Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science329, 811–817. doi: 10.1126/science.119281920616231
23. Walker L. M, Huber M, Doores K. J, Falkowska E, Pejchal R, Julien J.-P, et al. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature477, 466–470. doi: 10.1038/nature1037321849977
24. Mouquet H, Nussenzweig M. C, . (2013) HIV: Roadmaps to a vaccine. Nature496, 441–442. doi: 10.1038/nature1209123552894
25. Kwong P. D, Mascola J. R, Nabel G. J, . (2013) Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nature Rev. Immunol.13, 693–701. doi: 10.1038/nri3516
26. Klein F, Mouquet H, Dosenovic P, Scheid J. F, Scharf L, Nussenzweig M. C, . (2013) Antibodies in HIV-1 vaccine development and therapy. Science341, 1199–1204. doi: 10.1126/science.124114424031012
27. Wang S, Mata-Fink J, Kriegsman B, Hanson M, Irvine D. J, Eisen H. N, et al. (2015) Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies. Cell160, 785–797. doi: 10.1016/j.cell.2015.01.02725662010
28. Childs L. M, Baskerville E. B, Cobey S, . (2015) Trade-offs in antibody repertoires to complex antigens. Phil. Trans. R. Soc. B370. doi: 10.1098/rstb.2014.024526194759
29. Chaudhury S, Reifman J, Wallqvist A, . (2014) Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1. J. Immunol.193, 2073–2086. doi: 10.4049/jimmunol.140105425080483
30. Luo S, Perelson A. S, . (2015) Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising. Proc Natl Acad Sci USA112, 11654–11659. doi: 10.1073/pnas.150520711226324897
31. Perelson A. S, . (2002) Modelling viral and immune system dynamics. Nature Rev. Immunol.2, 28–36. doi: 10.1038/nri700
32. McMichael A. J, Borrow P, Tomaras G. D, Goonetilleke N, Haynes B. F, . (2009) The immune response during acute HIV-1 infection: clues for vaccine development. Nature Rev. Immunol.1011–23. doi: 10.1038/nri2674
33. Shankarappa R, Margolick J. B, Gange S. J, Rodrigo A. G, Upchurch D, Farzadegan H, et al. (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol.73, 10489–10502. 10559367
34. Lynch M, Walsh B, . (1998) Genetics and analysis of quantitative traits. (Sinauer Associates Inc).
35. Nourmohammad A, Held T, Lässig M, . (2013) Universality and predictability in molecular quantitative genetics. Curr. Opin. Genet. Dev.23, 684–693. doi: 10.1016/j.gde.2013.11.00124291213
36. Detours V, Perelson A. S, . (1999) Explaining high alloreactivity as a quantitative consequence of affinity-driven thymocyte selection. Proc. Natl. Acad. Sci. U.S.A.96, 5153–5158. doi: 10.1073/pnas.96.9.515310220434
37. Detours V, Perelson A. S, . (2000) The paradox of alloreactivity and self MHC restriction: quantitative analysis and statistics. Proc. Natl. Acad. Sci. U.S.A.97, 8479–8483. doi: 10.1073/pnas.97.15.847910900009
38. Lemey P, Rambaut A, Pybus O. G, . (2006) HIV evolutionary dynamics within and among hosts. AIDS Rev.8, 125–140. 17078483
39. Zanini F, Brodin J, Thebo L, Lanz C, Bratt G, Albert J, et al. (2015) Population genomics of intrapatient HIV-1 evolution. eLifedoi: 10.7554/eLife.11282
40. Fisher R. A, . (1930) The genetical theory of natural selection. (Oxford University Press, USA), 1st edition.
41. Price G. R, . (1970) Selection and covariance. Nature227, 520–521. doi: 10.1038/227520a05428476
42. Kessinger T. A, Perelson A. S, Neher R. A., (2009) Inferring HIV escape rates from multi-locus genotype data. Front. Immunol.4252.
43. Mustonen V, Lässig M, . (2009) From fitness landscapes to seascapes: non-equilibrium dynamics of selection and adaptation. Trends Genet.25, 111–119. doi: 10.1016/j.tig.2009.01.00219232770
44. Mustonen V, Lässig M, . (2010) Fitness flux and ubiquity of adaptive evolution. Proc. Natl. Acad. Sci. U.S.A.107, 4248–4253. doi: 10.1073/pnas.090795310720145113
45. Held T, Nourmohammad A, Lässig M, . (2014) Adaptive evolution of molecular phenotypes. J. Stat. Mech. Theor. Exp.2014, P09029. doi: 10.1088/1742-5468/2014/09/P09029
46. Blanquart F, Gandon S, . (2013) Time-shift experiments and patterns of adaptation across time and space. Ecol. Lett.16, 31–38. doi: 10.1111/ele.1200723034076
47. Hoehn K. B, Gall A, Bashford-Rogers R, Fidler S. J, Kaye S, Weber J. N, et al. (2015) Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals. Phil. Trans. R. Soc. B370. doi: 10.1098/rstb.2014.024126194755
48. Wyatt R, Sodroski J, . (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science280, 1884–1888. doi: 10.1126/science.280.5371.18849632381
49. Zhang Y, Meyer-Hermann M, George L. A, Figge M. T, Khan M, Goodall M, et al. (2013) Germinal center B cells govern their own fate via antibody feedback. The Journal of experimental medicine210, 457–464. doi: 10.1084/jem.2012015023420879
50. Neher R. A, Leitner T, . (2010) Recombination rate and selection strength in HIV intra-patient evolution. PLoS Comput. Biol.6, e1000660. doi: 10.1371/journal.pcbi.100066020126527
51. Chun T. W, Carruth L, Finzi D, Shen X, DiGiuseppe J. A, Taylor H, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature387, 183–188. doi: 10.1038/387183a09144289
52. Brockhurst M. A, Koskella B, . (2013) Experimental coevolution of species interactions. Trends Ecol. Evol.28, 367–375. doi: 10.1016/j.tree.2013.02.00923523051
53. Koskella B, Brockhurst M. A, . (2014) Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol. Rev.38, 916–931. doi: 10.1111/1574-6976.1207224617569
54. Hall A. R, Scanlan P. D, Morgan A. D, Buckling A, . (2011) Host-parasite coevolutionary arms races give way to fluctuating selection. Ecol. Lett.14, 635–642. doi: 10.1111/j.1461-0248.2011.01624.x21521436
55. Betts A, Kaltz O, Hochberg M. E, . (2014) Contrasted coevolutionary dynamics between a bacterial pathogen and its bacteriophages. Proc. Natl. Acad. Sci. U.S.A.111, 11109–11114. doi: 10.1073/pnas.140676311125024215
56. Agrawal A, Lively C. M, . (2002) Infection genetics: gene-for-gene versus matching-alleles models and all points in between. Evol. Ecol. Res.4, 91–107.
57. Fonville J. M, Wilks S. H, James S. L, Fox A, Ventresca M, Aban M, et al. (2014) Antibody landscapes after influenza virus infection or vaccination. Science346, 996–1000. doi: 10.1126/science.125642725414313
58. Verkoczy L, Kelsoe G, Moody M, Haynes B, . (2011) Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Curr. Opin. Immunol.23, 383–390. doi: 10.1016/j.coi.2011.04.00321524897
59. Kepler T. B, Munshaw S, Wiehe K, Zhang R, Yu J-S, Woods C. W, et al. (2014) Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation. Front. Immunol.5, 170. doi: 10.3389/fimmu.2014.0017024795717